Literature DB >> 10825379

Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.

M Itokawa1, Z Lin, N S Cai, C Wu, S Kitayama, J B Wang, G R Uhl.   

Abstract

Polar residues in dopamine transporter (DAT) transmembrane domains (TMs) are likely to act individually and even interactively in recognizing cocaine and dopamine. We initially evaluated the effects of alanine substitution mutants that remove the polar side chains from residues in each of the 12 putative DAT TMs on the recognition of dopamine and the cocaine analog CFT. Eleven combination mutants with multiple substitutions in DAT TMs 4, 5, 7, or 11 were then selected as candidates for more detailed evaluation based on mutation effects on dopamine and cocaine analog affinities. An evaluation of Gibbs free energy changes displayed by single and combined TM mutants (DeltaG(o) and DeltaDeltaG(o)(int)) reveals three categories of potential interactions among mutants: 1) independent, noncooperative interactions (five influenced CFT and two influenced dopamine affinities), 2) synergistic influences (two for CFT and four for dopamine), and 3) complementation of influences on CFT recognition (four mutants) or on dopamine affinity (five). Combined mutations in TMs 4 and 5 yield the largest DeltaDeltaG(o)(int) values for dopamine uptake. TMs 4 and 11 mutants provide the largest DeltaDeltaG(o)(int) for CFT binding. Interactions between residues lying in DAT TMs 4 and 5 support current DAT structural models that suggest the juxtaposition of these two TMs. These data also support contributions of TM 4 and 11 residues to a polar pocket important for cocaine recognition. These candidate interactive DAT polar domains provide larger target sites for compounds that could modulate specific DAT functions than those provided by single mutations alone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825379

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties.

Authors:  Mitchell Ho; Mariangela Segre
Journal:  Biochim Biophys Acta       Date:  2003-07-30

Review 2.  Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.

Authors:  Christopher K Surratt; Okechukwu T Ukairo; Suneetha Ramanujapuram
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

3.  Identification of a chloride ion binding site in Na+/Cl -dependent transporters.

Authors:  Lucy R Forrest; Sotiria Tavoulari; Yuan-Wei Zhang; Gary Rudnick; Barry Honig
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

4.  Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2beta anti-idiotypic monoclonal antibody possessing an internal image of cocaine.

Authors:  M Ho; M Segre
Journal:  Biochim Biophys Acta       Date:  2001-10-31

5.  Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.

Authors:  Rejwi Acharya Dahal; Akula Bala Pramod; Babita Sharma; Danielle Krout; James D Foster; Joo Hwan Cha; Jianjing Cao; Amy Hauck Newman; John R Lever; Roxanne A Vaughan; L Keith Henry
Journal:  J Biol Chem       Date:  2014-08-31       Impact factor: 5.157

6.  The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.

Authors:  Jufang Shan; Jonathan A Javitch; Lei Shi; Harel Weinstein
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

7.  Assessing the ability of sequence-based methods to provide functional insight within membrane integral proteins: a case study analyzing the neurotransmitter/Na+ symporter family.

Authors:  Dennis R Livesay; Patrick D Kidd; Sepehr Eskandari; Usman Roshan
Journal:  BMC Bioinformatics       Date:  2007-10-17       Impact factor: 3.169

8.  Spontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminus.

Authors:  George Khelashvili; Nathaniel Stanley; Michelle A Sahai; Jaime Medina; Michael V LeVine; Lei Shi; Gianni De Fabritiis; Harel Weinstein
Journal:  ACS Chem Neurosci       Date:  2015-08-17       Impact factor: 4.418

9.  Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.

Authors:  Pamela M Quizon; Yaxia Yuan; Yike Zhu; Yi Zhou; Matthew J Strauss; Wei-Lun Sun; Chang-Guo Zhan; Jun Zhu
Journal:  J Neuroimmune Pharmacol       Date:  2021-02-03       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.